ANGLE PLC (AIM:AGL, OTCQX:ANPCY) said it has presented a new poster at the 100th American Society for Clinical Pathology (ASCP) meeting in Chicago.
The poster, which describes the novel use of Papanicolaou (Pap) staining procedures with cells harvested from blood samples using ANGLE's Parsortix biopsy system, was selected as a finalist for a prestigious Blue Ribbon award for laboratory practice by ASCP judges.
Pap is a polychromatic cytopathological staining technique used to differentiate cells in a sample and is most commonly used as a screening method for cervical cancer.
In a statement, ANGLE chief executive, Andrew Newland, said: “I am delighted that the clinical laboratory team has achieved this recognition and look forward to seeing a positive impact on the commercial roll-out of the Parsortix system".